Retractable Technologies Q3 operating loss widens despite sales growth
RVP•Retractable Technologies' third-quarter 2026 net sales rose 39% year over year to $14.1 million, while its operating loss widened to $4.1 million from $3.7 million. Higher EasyPoint needle sales lifted revenue but weighed on gross margin.
1. Sales and operating loss
Net sales rose 39% year over year to $14.1 million in the third quarter of 2026. The operating loss widened to $4.1 million from $3.7 million a year earlier.
2. Sales mix and outlook
Growth was driven by increased EasyPoint needle orders. International net sales rose 52%, mainly on higher EasyPoint sales, which have lower average selling prices and margins. The company said uncertainty remains about the timing of future international orders and tariffs may affect costs in future periods; it is working to reduce tariff expenses through increased domestic production and strategic sourcing.




